首页 > 最新文献

Revista Espanola De Medicina Nuclear最新文献

英文 中文
Síndrome de discinesia apical transitoria (Tako-Tsubo) que simula un infarto agudo de miocardio [短暂性心尖功能障碍综合征(Tako-Tsubo)模拟急性心肌梗死]。
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.03.009
M.J. Carrero Lérida , M.C. Mariscal Cerrato , C. Dávila Arias , A. López Ruiz , J. Caballero Güeto

Transient apical dysfunction syndrome (TADS) is frequently misdiagnosed as an acute coronary syndrome (ACS). It is characterized by electrocardiographic alterations and elevated myocardial necrosis markers, accompanied by hypokinesia, akinesia or anteroapical dyskinesia, in absence of significant coronary disorders. It generally resolves in days or weeks with individualized support measures. We present the case of a female patient referred to our service for a myocardial perfusion imaging study due to a history suggestive of an acute coronary syndrome after a stressful event.

短暂性心尖功能障碍综合征(TADS)常被误诊为急性冠脉综合征(ACS)。其特征是心电图改变和心肌坏死标志物升高,伴有运动障碍、运动障碍或根尖前运动障碍,无明显的冠状动脉疾病。它通常在几天或几周内通过个性化的支持措施解决。我们提出的情况下,女性患者转介到我们的服务心肌灌注成像研究,由于历史提示急性冠状动脉综合征后应激事件。
{"title":"Síndrome de discinesia apical transitoria (Tako-Tsubo) que simula un infarto agudo de miocardio","authors":"M.J. Carrero Lérida ,&nbsp;M.C. Mariscal Cerrato ,&nbsp;C. Dávila Arias ,&nbsp;A. López Ruiz ,&nbsp;J. Caballero Güeto","doi":"10.1016/j.remn.2010.03.009","DOIUrl":"10.1016/j.remn.2010.03.009","url":null,"abstract":"<div><p>Transient apical dysfunction syndrome (TADS) is frequently misdiagnosed as an acute coronary syndrome (ACS). It is characterized by electrocardiographic alterations and elevated myocardial necrosis markers, accompanied by hypokinesia, akinesia or anteroapical dyskinesia, in absence of significant coronary disorders. It generally resolves in days or weeks with individualized support measures. We present the case of a female patient referred to our service for a myocardial perfusion imaging study due to a history suggestive of an acute coronary syndrome after a stressful event.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 107-111"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.03.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29368214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Agenda 议程
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2011.02.006
{"title":"Agenda","authors":"","doi":"10.1016/j.remn.2011.02.006","DOIUrl":"https://doi.org/10.1016/j.remn.2011.02.006","url":null,"abstract":"","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Page 137"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2011.02.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72272356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identificación preoperatoria mediante SPECT/TAC de un ganglio centinela intramamario en una paciente con cáncer de mama. Significado y relevancia clínica 乳腺癌患者胸内前哨神经节的SPECT/CT术前鉴定。意义和临床意义
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.09.008
A. Andrés, E. Prats, A. Santapau, L. Tardín, P. Razola, A. Parra, E.F. Rambalde, J. Banzo

We present the case of a patient with breast cancer who underwent selective sentinel lymph node biopsy. An intramammary sentinel lymph node was identified with SPECT/CT in the preoperative lymphoscintigraphy. We describe our diagnostic and therapeutic procedure regarding this finding and the literature review to evaluate the clinical significance of their identification and metastases, especially in regards to more appropriate axillary management. Further studies with more statistical significance are necessary to elucidate the most suitable attitude when an intramammary sentinel lymph node is identified with the lymphoscintigraphy.

我们报告了一例癌症患者,他接受了选择性前哨淋巴结活检。SPECT/CT在术前淋巴闪烁扫描中发现了一个乳腺内前哨淋巴结。我们描述了我们关于这一发现的诊断和治疗程序,以及文献综述,以评估其识别和转移的临床意义,特别是在更合适的腋窝管理方面。有必要进行更具统计学意义的进一步研究,以阐明当用淋巴闪烁扫描法确定乳内前哨淋巴结时最合适的态度。
{"title":"Identificación preoperatoria mediante SPECT/TAC de un ganglio centinela intramamario en una paciente con cáncer de mama. Significado y relevancia clínica","authors":"A. Andrés,&nbsp;E. Prats,&nbsp;A. Santapau,&nbsp;L. Tardín,&nbsp;P. Razola,&nbsp;A. Parra,&nbsp;E.F. Rambalde,&nbsp;J. Banzo","doi":"10.1016/j.remn.2010.09.008","DOIUrl":"https://doi.org/10.1016/j.remn.2010.09.008","url":null,"abstract":"<div><p>We present the case of a patient with breast cancer who underwent selective sentinel lymph node biopsy. An intramammary sentinel lymph node was identified with SPECT/CT in the preoperative lymphoscintigraphy. We describe our diagnostic and therapeutic procedure regarding this finding and the literature review to evaluate the clinical significance of their identification and metastases, especially in regards to more appropriate axillary management. Further studies with more statistical significance are necessary to elucidate the most suitable attitude when an intramammary sentinel lymph node is identified with the lymphoscintigraphy.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 101-103"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.09.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72272799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
EVIDENCIAS EN MEDICINA NUCLEAR. Selección de publicaciones, Enero-Junio 2010 核医学的证据。出版物选集,2010年1月至6月
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.12.003
{"title":"EVIDENCIAS EN MEDICINA NUCLEAR. Selección de publicaciones, Enero-Junio 2010","authors":"","doi":"10.1016/j.remn.2010.12.003","DOIUrl":"https://doi.org/10.1016/j.remn.2010.12.003","url":null,"abstract":"","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 124-133"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.12.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136529696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uso de la PET-18F-FDG en pacientes con sospecha de recurrencia de cáncer diferenciado de tiroides por anticuerpos anti-tiroglobulina elevados y rastreo 131I negativo PET-18F-FDG在疑似甲状腺癌复发的抗甲状腺球蛋白抗体升高和筛查131I阴性患者中的应用
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.10.012
S. Sanz Viedma , I. Borrego Dorado , J.R. Rodríguez Rodríguez , E. Navarro González , R. Vázquez Albertino , R. Fernández López , A. Agudo Martínez

Aim

To evaluate the utility of 18FFDG-PET for patients diagnosed of differentiated thyroid carcinoma who present risk of disease and invaluable levels of thyroglobulin (Tg) by the presence of antibodies antithyroglobulin (AbTg).

Material and methods

Retrospective study of 7 women of 40 years old and histological diagnosis of differentiated thyroid cancer (7 papillary tumours) that were sent to our department for the accomplishment of18FFDG-PET study because of suspicion of disease, due to 131I negative and high levels of AbTg, between the year 2002 and 2007. 11 PET scans were obtained after the intravenous injection of 370-434 MBq of 18FFDG in normoglycemia conditions and previous administration of muscle relaxant, hydration and diuretic. The results of 18FFDG-PET scans were confirmed by pathologic examination or clinical outcome and radiographic examination for more than 24 months.

Results

The prevalence of recurrence in our population was 57.14%. All patients presented levels of Tg lower than 3 ng/dl and AbTg superior to 200 UI/ml. Three patients had precedent thyroiditis. Out of 11 scans performed 3 of them were negative and 8 cases were found positive. It ruled out the existence of disease in three patients and localized the presence of recurrence in 4 patients.

Conclusion

18FFDG-PET

CONCLUSION: 18F-FDG-PET is a useful diagnostic tool for the detection of recurrence as well as to rule out the existence of disease with a high accuracy, in patients with differentiated thyroid carcinoma with 131I whole body scan negative but with pathological elevation of antithyroglobulin antibodies.

目的评价18FFDG-PET在诊断为分化型甲状腺癌的患者中的应用价值,这些患者存在疾病风险,并且通过抗甲状腺球蛋白(AbTg)抗体检测甲状腺球蛋白(Tg)水平。材料与方法回顾性分析2002 ~ 2007年因131I阴性、AbTg水平高而怀疑患病,送我科完成18ffdg - pet检查的组织学诊断为分化型甲状腺癌(乳头状肿瘤7例)的40岁女性7例。11例患者在血糖正常的情况下静脉注射370-434 MBq的18FFDG,并给予肌肉松弛剂、水合剂和利尿剂。18FFDG-PET扫描结果经24个月以上的病理检查或临床结果及影像学检查证实。结果本组患者复发率为57.14%。所有患者的Tg水平均低于3 ng/dl, AbTg水平优于200 UI/ml。3例患者既往有甲状腺炎。在11次扫描中,3例为阴性,8例为阳性。3例患者排除了疾病的存在,4例患者定位了复发的存在。结论:18F-FDG-PET对131I全身扫描阴性、抗甲状腺球蛋白病理性升高的分化型甲状腺癌患者,是一种检测复发、排除疾病存在的有效诊断工具,准确率高。
{"title":"Uso de la PET-18F-FDG en pacientes con sospecha de recurrencia de cáncer diferenciado de tiroides por anticuerpos anti-tiroglobulina elevados y rastreo 131I negativo","authors":"S. Sanz Viedma ,&nbsp;I. Borrego Dorado ,&nbsp;J.R. Rodríguez Rodríguez ,&nbsp;E. Navarro González ,&nbsp;R. Vázquez Albertino ,&nbsp;R. Fernández López ,&nbsp;A. Agudo Martínez","doi":"10.1016/j.remn.2010.10.012","DOIUrl":"10.1016/j.remn.2010.10.012","url":null,"abstract":"<div><h3>Aim</h3><p>To evaluate the utility of <sup>18F</sup>FDG-PET for patients diagnosed of differentiated thyroid carcinoma who present risk of disease and invaluable levels of thyroglobulin (Tg) by the presence of antibodies antithyroglobulin (AbTg).</p></div><div><h3>Material and methods</h3><p>Retrospective study of 7 women of 40 years old and histological diagnosis of differentiated thyroid cancer (7 papillary tumours) that were sent to our department for the accomplishment of<sup>18F</sup>FDG-PET study because of suspicion of disease, due to <sup>131</sup>I negative and high levels of AbTg, between the year 2002 and 2007. 11 PET scans were obtained after the intravenous injection of 370-434 MBq of <sup>18F</sup>FDG in normoglycemia conditions and previous administration of muscle relaxant, hydration and diuretic. The results of <sup>18F</sup>FDG-PET scans were confirmed by pathologic examination or clinical outcome and radiographic examination for more than 24 months.</p></div><div><h3>Results</h3><p>The prevalence of recurrence in our population was 57.14%. All patients presented levels of Tg lower than 3 ng/dl and AbTg superior to 200 UI/ml. Three patients had precedent thyroiditis. Out of 11 scans performed 3 of them were negative and 8 cases were found positive. It ruled out the existence of disease in three patients and localized the presence of recurrence in 4 patients.</p></div><div><h3>Conclusion</h3><p><sup>18F</sup>FDG-PET</p><p>CONCLUSION: 18F-FDG-PET is a useful diagnostic tool for the detection of recurrence as well as to rule out the existence of disease with a high accuracy, in patients with differentiated thyroid carcinoma with <sup>131</sup>I whole body scan negative but with pathological elevation of antithyroglobulin antibodies.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 77-82"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.10.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29684157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Surveillance of radiopharmaceuticals in Latin American: an alert 拉丁美洲放射性药物监测:警报
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.10.010
R. Santos-Oliveira , S. Weiss Smith , M. de Souza Albernaz , J. Augusto Bordim , L. Jorge Antunes
{"title":"Surveillance of radiopharmaceuticals in Latin American: an alert","authors":"R. Santos-Oliveira ,&nbsp;S. Weiss Smith ,&nbsp;M. de Souza Albernaz ,&nbsp;J. Augusto Bordim ,&nbsp;L. Jorge Antunes","doi":"10.1016/j.remn.2010.10.010","DOIUrl":"10.1016/j.remn.2010.10.010","url":null,"abstract":"","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 134-136"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.10.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29684158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Noticias 新闻
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2011.02.007
{"title":"Noticias","authors":"","doi":"10.1016/j.remn.2011.02.007","DOIUrl":"https://doi.org/10.1016/j.remn.2011.02.007","url":null,"abstract":"","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 138-139"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2011.02.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72272357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valor pronóstico de la gammagrafía de perfusión miocárdica con 201Tl normal en el postinfarto agudo de miocardio 201TL正常心肌灌注显像对急性心肌梗塞后的预后价值
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.09.006
F.G. Gallardo , M.V. Gómez , I. Terol

Objective

The purpose of this work has been to determine the prognostic value of normal thallium-201 myocardial perfusion scintigraphy (MPS) in patients who had suffered myocardial infarction in the three months prior to the examination.

Material and methods

A stress test followed by 201Tl Gated SPECT was performed. A follow-up was made of 63 patients with normal perfusion scintigraphy. According to the MPS results, the patients were divided into 2 groups. Group I (n = 63; 57% males, age 65 ± 12), patients with normal MPS, and group II (n = 60; 81% males, age 64 ± 10), patients with abnormal MPS. The appearance of a new infarction or cardiac death occurring during this period (63 ± 3 months) was analyzed. The appearance of events was related with the cardiovascular risk factors, perfusion study and ventricular function.

Results

Five events occurred in group I in 4 patients: 3 new infarctions and 2 cardiac deaths. In group II, there were 18 events in 14 patients: 8 new infarctions and 10 cardiac deaths (p < 0,0001). The events were related with age, time from MPS, diabetes, size of perfusion defect and post stress ventricular ejection fraction. Mean survival en group I was 108 months (103–112) and in group II 97 (88–107) (p = 0,01).

Conclusion

Patients with normal MPS had fewer major events than patients with abnormal MPS. The size of MPS has been related with the appearance of events. A depressed post-stress left ventricular ejection fraction has a poor prognosis.

目的本工作的目的是确定正常铊-201心肌灌注闪烁显像(MPS)对检查前三个月内发生心肌梗死的患者的预后价值。材料和方法进行应力测试,然后进行201Tl门控SPECT。对63例正常灌注闪烁显像的患者进行了随访。根据MPS结果,将患者分为2组。第一组(n=63;57%男性,年龄65±12)为MPS正常患者,第二组(n=60;81%男性,年龄64±10)为MPS异常患者。分析在此期间(63±3个月)出现的新梗死或心脏性死亡。事件的出现与心血管危险因素、灌注研究和心室功能有关。结果I组4例患者发生5例事件:3例新发梗死,2例心脏死亡。在第二组中,14名患者中发生了18起事件:8例新梗死和10例心脏死亡(p<;00001)。这些事件与年龄、MPS发生时间、糖尿病、灌注缺陷大小和应激后心室射血分数有关。第一组的平均生存期为108个月(103-112),第二组为97个月(88-107)(p=0.01)。结论MPS正常患者的重大事件少于MPS异常患者。MPS的大小与事件的出现有关。应激后左心室射血分数降低预后不良。
{"title":"Valor pronóstico de la gammagrafía de perfusión miocárdica con 201Tl normal en el postinfarto agudo de miocardio","authors":"F.G. Gallardo ,&nbsp;M.V. Gómez ,&nbsp;I. Terol","doi":"10.1016/j.remn.2010.09.006","DOIUrl":"https://doi.org/10.1016/j.remn.2010.09.006","url":null,"abstract":"<div><h3>Objective</h3><p>The purpose of this work has been to determine the prognostic value of normal thallium-201 myocardial perfusion scintigraphy (MPS) in patients who had suffered myocardial infarction in the three months prior to the examination.</p></div><div><h3>Material and methods</h3><p>A stress test followed by <sup>201</sup>Tl Gated SPECT was performed. A follow-up was made of 63 patients with normal perfusion scintigraphy. According to the MPS results, the patients were divided into 2 groups. Group I (n<!--> <!-->=<!--> <!-->63; 57% males, age 65<!--> <!-->±<!--> <!-->12), patients with normal MPS, and group II (n<!--> <!-->=<!--> <!-->60; 81% males, age 64<!--> <!-->±<!--> <!-->10), patients with abnormal MPS. The appearance of a new infarction or cardiac death occurring during this period (63<!--> <!-->±<!--> <!-->3 months) was analyzed. The appearance of events was related with the cardiovascular risk factors, perfusion study and ventricular function.</p></div><div><h3>Results</h3><p>Five events occurred in group I in 4 patients: 3 new infarctions and 2 cardiac deaths. In group II, there were 18 events in 14 patients: 8 new infarctions and 10 cardiac deaths (p<!--> <!-->&lt;<!--> <!-->0,0001). The events were related with age, time from MPS, diabetes, size of perfusion defect and post stress ventricular ejection fraction. Mean survival en group I was 108 months (103–112) and in group II 97 (88–107) (p<!--> <!-->=<!--> <!-->0,01).</p></div><div><h3>Conclusion</h3><p>Patients with normal MPS had fewer major events than patients with abnormal MPS. The size of MPS has been related with the appearance of events. A depressed post-stress left ventricular ejection fraction has a poor prognosis.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 83-87"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.09.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72272726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
PET de doble fase con 18F-FDOPA como instrumento para la caracterización de tumores cerebrales 以18f -酞多巴为仪器的双相PET鉴定脑肿瘤
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.11.007
M. González-Forero, E. Prieto, I. Domínguez, C. Vigil, I. Peñuelas, J. Arbizu

18F-FDOPA is an amino acid analogue used to evaluate presynaptic dopaminergic activity, which has aroused great interest in neuro-oncology. We have evaluated five 18F-FDOPA PET studies of patients referred for study of parkinsonian syndrome. Two subjects had previously treated high-grade brain tumors, one nonspecific brain injury, and 2 subjects presented unexpected tumoral lesions. For all lesions SUVmax, time to SUVmax and tumor-to-normal grey matter SUVmax rate (T/N) were calculated, and 90 minutes 18F-FDOPA kinetics were analyzed. Tumor lesions corresponded to three malignant neurocytomas, one meningioma, one pineocytoma and one intrasinusal hemangioma. Both malignant and benign tumors exhibited high uptake of 18F-FDOPA well above the normal cortex. However, the analysis of the curve uptake displayed characteristic patterns that facilitate the characterization of tumor lesions. A dual phase maximum uptake was observed, with an early 10 minutes uptake in malignant lesions, and a late 60 to 90 minutes uptake in benign or low grade lesions.

18F-FDOPA是一种用于评估突触前多巴胺能活性的氨基酸类似物,在神经肿瘤学领域引起了极大的兴趣。我们评估了5例帕金森综合征患者的18F-FDOPA PET研究。2名受试者先前治疗过高级别脑肿瘤,1名非特异性脑损伤,2名受试者出现意外的肿瘤病变。对所有病变SUVmax,计算SUVmax时间和肿瘤与正常灰质SUVmax比率(T/N),分析90分钟18F-FDOPA动力学。肿瘤病变对应3例恶性神经细胞瘤、1例脑膜瘤、1例松果体细胞瘤和1例血管瘤。恶性和良性肿瘤均表现出18F-FDOPA的高摄取,远高于正常皮层。然而,对曲线摄取的分析显示了有助于肿瘤病变表征的特征模式。观察到双期最大摄取,恶性病变早10分钟摄取,良性或低级别病变晚60至90分钟摄取。
{"title":"PET de doble fase con 18F-FDOPA como instrumento para la caracterización de tumores cerebrales","authors":"M. González-Forero,&nbsp;E. Prieto,&nbsp;I. Domínguez,&nbsp;C. Vigil,&nbsp;I. Peñuelas,&nbsp;J. Arbizu","doi":"10.1016/j.remn.2010.11.007","DOIUrl":"10.1016/j.remn.2010.11.007","url":null,"abstract":"<div><p><sup>18</sup>F-FDOPA is an amino acid analogue used to evaluate presynaptic dopaminergic activity, which has aroused great interest in neuro-oncology. We have evaluated five <sup>18</sup>F-FDOPA PET studies of patients referred for study of parkinsonian syndrome. Two subjects had previously treated high-grade brain tumors, one nonspecific brain injury, and 2 subjects presented unexpected tumoral lesions. For all lesions SUVmax, time to SUVmax and tumor-to-normal grey matter SUVmax rate (T/N) were calculated, and 90<!--> <!-->minutes <sup>18</sup>F-FDOPA kinetics were analyzed. Tumor lesions corresponded to three malignant neurocytomas, one meningioma, one pineocytoma and one intrasinusal hemangioma. Both malignant and benign tumors exhibited high uptake of <sup>18</sup>F-FDOPA well above the normal cortex. However, the analysis of the curve uptake displayed characteristic patterns that facilitate the characterization of tumor lesions. A dual phase maximum uptake was observed, with an early 10<!--> <!-->minutes uptake in malignant lesions, and a late 60 to 90<!--> <!-->minutes uptake in benign or low grade lesions.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 88-93"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.11.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29684160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
PET-TAC con 18F-FDG tras llenado retrógrado vesical en el estudio de patología pélvica maligna 膀胱逆行填充后PET-TAC与18F-FDG在盆腔恶性病理研究中的应用
Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.10.013
A.M. García Vicente, A. Núñez García, A. Palomar Muñoz, J.P. Pilkington Woll, M.E. Bellón Guardia, B. González García, A. Soriano Castrejón

Aim

To assess the role of PET/CT with retrograde filling of urinary bladder (RFUB) in the assessment of pelvic malignancy in patients with urothelial or gynecological tumors.

Material and methods

A retrospective longitudinal analysis based on 62 studies belonging to 52 patients was performed. All of them had a history of pelvic malignancy (29 urothelial and 23 gynecological) and 42 had undergone previous treatments. All patients underwent a standard PET/CT protocol. Inclusion criteria were radiological alterations in pelvic organs or increased urinary activity of 18F-FDG that hindered evaluation of the pelvic structures. Pathological pelvic locations were assessed as the additional value of PET/CT with RFUB. The pathologic lesions were histologically or clinically evaluated with a minimum follow-up of 12 months.

Results

Pelvic malignancy was confirmed in 33 cases, 16 of which were of urothelial origin. A total of 35/62 studies showed a pathologic PET/CT in pelvis, 4 of them were false positive and 2 false negative. In 19 cases, malignancy was detected in the bladder wall, 16 of which were true positive. No false negative was detected. Regarding standard imaging acquisition, RFUB helped to confirm or rule out bladder and/or gynecological disease in 54 cases.

Conclusion

Retrograde bladder filling is a highly recommended technique in the assessment of malignant pelvic disease, especially of bladder origin.

目的探讨PET/CT逆行膀胱充血(RFUB)在泌尿上皮或妇科肿瘤患者盆腔恶性肿瘤诊断中的价值。材料与方法对52例患者的62项研究进行回顾性纵向分析。所有患者均有盆腔恶性肿瘤病史(29例泌尿系,23例妇科),42例既往治疗。所有患者均接受标准PET/CT检查。纳入标准是盆腔器官的影像学改变或18F-FDG的尿活性增加,这阻碍了盆腔结构的评估。病理盆腔位置作为RFUB的PET/CT附加价值进行评估。病理病变进行组织学或临床评估,至少随访12个月。结果33例确诊为盆腔恶性肿瘤,其中16例来源于尿路上皮。62例研究中有35例显示骨盆病理PET/CT,其中4例假阳性,2例假阴性。19例膀胱壁检出恶性肿瘤,其中16例为真阳性。未检测到假阴性。在标准影像采集方面,54例RFUB帮助确诊或排除膀胱和/或妇科疾病。结论膀胱逆行填充术是评价恶性盆腔疾病,尤其是膀胱源性盆腔疾病的有效方法。
{"title":"PET-TAC con 18F-FDG tras llenado retrógrado vesical en el estudio de patología pélvica maligna","authors":"A.M. García Vicente,&nbsp;A. Núñez García,&nbsp;A. Palomar Muñoz,&nbsp;J.P. Pilkington Woll,&nbsp;M.E. Bellón Guardia,&nbsp;B. González García,&nbsp;A. Soriano Castrejón","doi":"10.1016/j.remn.2010.10.013","DOIUrl":"10.1016/j.remn.2010.10.013","url":null,"abstract":"<div><h3>Aim</h3><p>To assess the role of PET/CT with retrograde filling of urinary bladder (RFUB) in the assessment of pelvic malignancy in patients with urothelial or gynecological tumors.</p></div><div><h3>Material and methods</h3><p>A retrospective longitudinal analysis based on 62 studies belonging to 52 patients was performed. All of them had a history of pelvic malignancy (29 urothelial and 23 gynecological) and 42 had undergone previous treatments. All patients underwent a standard PET/CT protocol. Inclusion criteria were radiological alterations in pelvic organs or increased urinary activity of <sup>18</sup>F-FDG that hindered evaluation of the pelvic structures. Pathological pelvic locations were assessed as the additional value of PET/CT with RFUB. The pathologic lesions were histologically or clinically evaluated with a minimum follow-up of 12 months.</p></div><div><h3>Results</h3><p>Pelvic malignancy was confirmed in 33 cases, 16 of which were of urothelial origin. A total of 35/62 studies showed a pathologic PET/CT in pelvis, 4 of them were false positive and 2 false negative. In 19 cases, malignancy was detected in the bladder wall, 16 of which were true positive. No false negative was detected. Regarding standard imaging acquisition, RFUB helped to confirm or rule out bladder and/or gynecological disease in 54 cases.</p></div><div><h3>Conclusion</h3><p>Retrograde bladder filling is a highly recommended technique in the assessment of malignant pelvic disease, especially of bladder origin.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 71-76"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.10.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29684156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Revista Espanola De Medicina Nuclear
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1